Drivers of calcium oxalate stone formation in the octogenarian population.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 31 05 2023
accepted: 06 09 2023
medline: 4 12 2023
pubmed: 17 10 2023
entrez: 17 10 2023
Statut: ppublish

Résumé

American Urological Association (AUA) guidelines suggest metabolic testing via 24-h urine studies in high-risk, interested first-time stone formers, and recurrent stone formers. If metabolic testing is not available or otherwise not feasible, clinicians may need to utilize empiric therapy. Debility and social barriers, particularly in the elderly population, may limit the practicality of metabolic testing, and therefore, empiric therapy is of particular importance. The aim of this study is to identify whether unique urinary metabolic abnormality profiles exist for octogenarians with calcium oxalate kidney stones, as this may guide empiric stone prevention therapy more precisely in this population. Patients with calcium oxalate stones from a single academic kidney stone center in New York, NY, were retrospectively identified in our prospectively managed database. Patient data, including demographic, clinical information, and baseline 24-h urine studies, were collected before initiating any treatment. Subjects were stratified by age (≤ 40, 41-59, 60-79, and ≥ 80 years) to compare the metabolic urinary abnormality profiles between octogenarians and other age groups. Subgroup analyses were also performed to compare results by gender and by the presence of underlying kidney dysfunction. Comparative statistical analysis was carried out using Chi-square tests, Mann-Whitney U tests, and t-tests where appropriate. Hypocitraturia, low urine pH, and low urine volume were most common in older patients, particularly in octogenarians. Hypercalciuria, hypernatriuria, and hyperuricosuria were more apparent in younger groups. With increasing age, hypocitraturia, low urine pH, and low urine volume were more prevalent on 24-h urine metabolic testing. We hypothesize increased comorbidity, including medical renal disease, polypharmacy, and dehydration are possible factors contributing to this unique profile. We suggest that empiric therapy targeted towards this profile is important in very elderly stone formers in whom 24-h urine testing may not be possible. Increased hydration, increased fruit and vegetable intake, and low-dose alkali therapy are easy measures to accomplish this.

Identifiants

pubmed: 37847263
doi: 10.1007/s00345-023-04619-1
pii: 10.1007/s00345-023-04619-1
doi:

Substances chimiques

Calcium Oxalate 2612HC57YE
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3713-3721

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR (2014) Medical management of kidney stones: AUA guideline. J Urol 192:316–324
doi: 10.1016/j.juro.2014.05.006 pubmed: 24857648
Ghiraldi EM, Braitman LE, Friedlander JI (2020) Factors associated with compliance with 24-hour urine collection. Urology 142:65–69
doi: 10.1016/j.urology.2020.03.047 pubmed: 32305538
Miler M, Simundić AM (2013) Low level of adherence to instructions for 24-hour urine collection among hospital outpatients. Biochem Med (Zagreb) 23:316–320
doi: 10.11613/BM.2013.038 pubmed: 24266301
Eredics K, Drerup M, Özsoy M, Wehrberger C, Lenz M, Ramesmayer C, Stolzlechner P, Zanier J, Falkensammer CE, Handjiev I, Wasserscheid A, Seklehner S (2023) Active stone removal is a safe option for ocotogenarians and nonagenarians with nephrolithiasis. World J Urol 41:849–856
doi: 10.1007/s00345-023-04304-3 pubmed: 36754879
Juliebø-Jones P, Moen CA, Haugland JN, Gjengstø P, Æsøy MS, Beisland C, Ulvik Ø (2023) Ureteroscopy for stone disease in extremely elderly patients (≥85 Years): outcomes and lessons learned. J Endourol 37:245–250
doi: 10.1089/end.2022.0665 pubmed: 36458461
Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 134:1242–1244
doi: 10.1016/S0022-5347(17)47703-2 pubmed: 3840540
Miller NL and Borofsky MS. Evaluation and Medical Management of Urinary Lithiasis. In: Partin AW, editors. Campbell-Walsh-Wein Urology. 12. Philadelphia, PA: Elsevier; 2020. p. 2036–2068.
Goldfarb DS (2019) Empiric therapy for kidney stones. Urolithiasis 47:107–113
doi: 10.1007/s00240-018-1090-6 pubmed: 30478476
McGuire BB, Bhanji Y, Sharma V, Frainey BT, McClean M, Dong C, Rimar K, Perry KT, Nadler RB (2015) Predicting patients with inadequate 24- or 48-hour urine collections at time of metabolic stone evaluation. J Endourol 29:730–735
doi: 10.1089/end.2014.0544 pubmed: 25423010
Divo MJ, Martinez CH, Mannino DM (2014) Ageing and the epidemiology of multimorbidity. Eur Respir J 44:1055–1068
doi: 10.1183/09031936.00059814 pubmed: 25142482 pmcid: 4918092
Fakhouri THI, Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity among older adults in the United States, 2007–2010. CDC. Updated November 6, 2015. 2023.
Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2:883–888
doi: 10.2215/CJN.00670207 pubmed: 17702734
Lavizzo-Mourey RJ (1987) Dehydration in the elderly: a short review. J Natl Med Assoc 79:1033–1038
pubmed: 3316670 pmcid: 2625510
Nakanishi N, Fukui M, Tanaka M, Toda H, Imai S, Yamazaki M, Hasegawa G, Oda Y, Nakamura N (2012) Low urine pH Is a predictor of chronic kidney disease. Kidney Blood Press Res 35:77–81
doi: 10.1159/000330487 pubmed: 21912182
Leslie SW, Bashir K (2023) Hypocitraturia And Renal Calculi. In: editors. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC
Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, Chowdhury M, Seitz DP (2022) Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis. BMC Geriatr 22:601
doi: 10.1186/s12877-022-03279-x pubmed: 35854209 pmcid: 9297624
Otto BJ, Bozorgmehri S, Kuo J, Canales M, Bird VG, Canales B (2017) Age, body mass index, and gender predict 24-hour urine parameters in recurrent idiopathic calcium oxalate stone formers. J Endourol 31:1335–1341
doi: 10.1089/end.2017.0352 pubmed: 29084490
Walker V, Stansbridge EM, Griffin DG (2013) Demography and biochemistry of 2800 patients from a renal stones clinic. Ann Clin Biochem 50:127–139
doi: 10.1258/acb.2012.012122 pubmed: 23431484
Karabacak OR, Ipek B, Ozturk U, Demirel F, Saltas H, Altug U (2010) Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease. Urology 76:238–241
doi: 10.1016/j.urology.2010.01.036 pubmed: 20350756
Mai Z, Li X, Jiang C, Liu Y, Chen Y, Wu W, Zeng G (2019) Comparison of metabolic changes for stone risks in 24-hour urine between non- and postmenopausal women. PLoS ONE 14:e0208893
doi: 10.1371/journal.pone.0208893 pubmed: 30677034 pmcid: 6345460

Auteurs

Raymond Khargi (R)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA. Raymond.khargi2@mountsinai.org.

Ryan M Blake (RM)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA.

Alan J Yaghoubian (AJ)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA.

Caroline Canning (C)

Department of Urology, SUNY Downstate Health Sciences University, New York, USA.

Alexander Fang (A)

Department of Urology, SUNY Downstate Health Sciences University, New York, USA.

Christopher Connors (C)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA.

Blair Gallante (B)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA.

Anna Ricapito (A)

Department of Urology and Kidney Transplant, University of Foggia, Foggia, Italy.

Johnathan A Khusid (JA)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA.

William M Atallah (WM)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA.

Mantu Gupta (M)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH